Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
4.88 USD -2.89% Intraday chart for Affimed N.V. -9.80% -21.92%
Jun. 12 Transcript : Affimed N.V., Q1 2024 Earnings Call, Jun 12, 2024
Jun. 12 Affimed N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AFFIMED N.V. Stock Affimed N.V.
 74.31M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
ARGENX SE Stock argenx SE
 25.83B -
BIONTECH SE Stock BioNTech SE
 19.42B -
GENMAB A/S Stock Genmab A/S
 16.2B
  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. Charts Affimed N.V.
  5. Sector Chart